Concise Review: Prospects of Bone Marrow Mononuclear Cells and Mesenchymal Stem Cells for Treating Status Epilepticus and Chronic Epilepsy. (Q38410150)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25851047 AND SRC:MED&resulttype=core&format=json

4 March 2020

review article

1 reference

title

Concise Review: Prospects of Bone Marrow Mononuclear Cells and Mesenchymal Stem Cells for Treating Status Epilepticus and Chronic Epilepsy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25851047 AND SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

mesenchymal stem cell

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25851047 AND SRC:MED&resulttype=core&format=json

4 March 2020

author name string

Satish Agadi

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25851047 AND SRC:MED&resulttype=core&format=json

4 March 2020

publication date

13 May 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25851047 AND SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25851047 AND SRC:MED&resulttype=core&format=json

4 March 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25851047 AND SRC:MED&resulttype=core&format=json

4 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25851047 AND SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

2093-2103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25851047 AND SRC:MED&resulttype=core&format=json

Early identification of refractory epilepsy

4 March 2020

cites work

1 reference

Surgical versus medical treatment for refractory epilepsy: outcomes beyond seizure control

21 January 2018

1 reference

Deep brain stimulation for epilepsy

21 January 2018

1 reference

Evidence-based guideline update: vagus nerve stimulation for the treatment of epilepsy: report of the guideline development subcommittee of the american academy of neurology.

21 January 2018

1 reference

Cell and gene therapies in epilepsy--promising avenues or blind alleys?

21 January 2018

1 reference

Progress in cell grafting therapy for temporal lobe epilepsy

21 January 2018

1 reference

Overexpression of adenosine kinase in cortical astrocytes and focal neocortical epilepsy in mice

21 January 2018

1 reference

Gene therapy in epilepsy-is it time for clinical trials?

21 January 2018

1 reference

Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsy

21 January 2018

1 reference

Repair of the injured adult hippocampus through graft-mediated modulation of the plasticity of the dentate gyrus in a rat model of temporal lobe epilepsy.

21 January 2018

1 reference

Gene therapy in status epilepticus

21 January 2018

1 reference

21 January 2018

Gene therapy in epilepsy

1 reference

Hippocampal injury-induced cognitive and mood dysfunction, altered neurogenesis, and epilepsy: can early neural stem cell grafting intervention provide protection?

21 January 2018

1 reference

Grafting of striatal precursor cells into hippocampus shortly after status epilepticus restrains chronic temporal lobe epilepsy.

21 January 2018

1 reference

Reduction of seizures by transplantation of cortical GABAergic interneuron precursors into Kv1.1 mutant mice

21 January 2018

1 reference

GABA progenitors grafted into the adult epileptic brain control seizures and abnormal behavior

21 January 2018

1 reference

Interneurons from embryonic development to cell-based therapy

21 January 2018

1 reference

hPSC-derived maturing GABAergic interneurons ameliorate seizures and abnormal behavior in epileptic mice

21 January 2018

1 reference

Strategies for promoting anti-seizure effects of hippocampal fetal cells grafted into the hippocampus of rats exhibiting chronic temporal lobe epilepsy.

21 January 2018

1 reference

Lessons from human teratomas to guide development of safe stem cell therapies.

21 January 2018

1 reference

Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases

21 January 2018

1 reference

Functional recovery after severe CNS trauma: Current perspectives for cell therapy with bone marrow stromal cells

21 January 2018

1 reference

The potential use of adult stem cells for the treatment of multiple sclerosis and other neurodegenerative disorders

21 January 2018

1 reference

Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study

21 January 2018

1 reference

Cell therapy for multiple sclerosis

21 January 2018

1 reference

Bone marrow stem cells in experimental stroke

21 January 2018

1 reference

The stem cell secretome and its role in brain repair

21 January 2018

1 reference

Mesenchymal stem cell therapy for the treatment of amyotrophic lateral sclerosis: signals for hope?

21 January 2018

1 reference

Harnessing the stem cell potential: a case for neural stem cell therapy

21 January 2018

1 reference

Are clinical trials with mesenchymal stem/progenitor cells too far ahead of the science? Lessons from experimental hematology

21 January 2018

1 reference

Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis

21 January 2018

1 reference

Clinical trials for stem cell therapies

21 January 2018

1 reference

Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials

21 January 2018

1 reference

Intranasally administered mesenchymal stem cells promote a regenerative niche for repair of neonatal ischemic brain injury

21 January 2018

1 reference

Intrathecal delivery of mesenchymal stromal cells protects the structure of altered perineuronal nets in SOD1 rats and amends the course of ALS.

21 January 2018

1 reference

Intraperitoneal infusion of mesenchymal stem/stromal cells prevents experimental autoimmune uveitis in mice

21 January 2018

1 reference

Intraperitoneal and intravenous deliveries are not comparable in terms of drug efficacy and cell distribution in neonatal mice with hypoxia-ischemia

21 January 2018

1 reference

The current landscape of adipose-derived stem cells in clinical applications

21 January 2018

1 reference

Concise reviews: Characteristics and potential applications of human dental tissue-derived mesenchymal stem cells

21 January 2018

1 reference

Discarded Wharton jelly of the human umbilical cord: a viable source for mesenchymal stromal cells

21 January 2018

1 reference

Mesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic properties

21 January 2018

1 reference

Practice parameter: diagnostic assessment of the child with status epilepticus (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society

21 January 2018

1 reference

Time-critical neurological emergencies: the unfulfilled role for point-of-care testing.

21 January 2018

1 reference

Guidelines for Epidemiologic Studies on Epilepsy. Commission on Epidemiology and Prognosis, International League Against Epilepsy

21 January 2018

1 reference

A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia

21 January 2018

1 reference

Prolonged epileptic seizures in primates. Ischemic cell change and its relation to ictal physiological events

21 January 2018

1 reference

Incidence and mortality of generalized convulsive status epilepticus in California

21 January 2018

1 reference

Outcome of paediatric convulsive status epilepticus: a systematic review.

21 January 2018

1 reference

Developmental outcome after a single episode of status epilepticus

21 January 2018

1 reference

Recognition memory is impaired in children after prolonged febrile seizures.

21 January 2018

1 reference

Early developmental outcomes in children following convulsive status epilepticus: a longitudinal study.

21 January 2018

1 reference

Outcome of severe refractory status epilepticus in children

21 January 2018

1 reference

Refractory status epilepticus: frequency, risk factors, and impact on outcome

21 January 2018

1 reference

Mechanisms of epileptogenesis and potential treatment targets

21 January 2018

1 reference

Origins of temporal lobe epilepsy: febrile seizures and febrile status epilepticus

21 January 2018

1 reference

Molecular biomarkers of epileptogenesis

21 January 2018

1 reference

Defining “epileptogenesis” and identifying “antiepileptogenic targets” in animal models of acquired temporal lobe epilepsy is not as simple as it might seem

21 January 2018

1 reference

Prevention of seizures and reorganization of hippocampal functions by transplantation of bone marrow cells in the acute phase of experimental epilepsy

21 January 2018

1 reference

Early transplantation of bone marrow mononuclear cells promotes neuroprotection and modulation of inflammation after status epilepticus in mice by paracrine mechanisms

21 January 2018

1 reference

Antiepileptic and neuroprotective effects of human umbilical cord blood mononuclear cells in a pilocarpine-induced epilepsy model.

21 January 2018

1 reference

Density gradient centrifugation compromises bone marrow mononuclear cell yield

21 January 2018

1 reference

Human mesenchymal stem cell grafts engineered to release adenosine reduce chronic seizures in a mouse model of CA3-selective epileptogenesis

21 January 2018

1 reference

Genetically engineered bone marrow mesenchymal stem cells improve functional outcome in a rat model of epilepsy.

21 January 2018

1 reference

Why should mesenchymal stem cells (MSCs) cure autoimmune diseases?

21 January 2018

1 reference

Do structural changes in GABA neurons give rise to the epileptic state?

21 January 2018

1 reference

Concise review: prospects of stem cell therapy for temporal lobe epilepsy.

21 January 2018

1 reference

Differentiation and functional incorporation of embryonic stem cell-derived GABAergic interneurons in the dentate gyrus of mice with temporal lobe epilepsy.

21 January 2018

1 reference

Bone marrow mononuclear cells reduce seizure frequency and improve cognitive outcome in chronic epileptic rats.

21 January 2018

1 reference

Transplantation of bone marrow mononuclear cells decreases seizure incidence, mitigates neuronal loss and modulates pro-inflammatory cytokine production in epileptic rats

21 January 2018

1 reference

The imbalanced expression of adenosine receptors in an epilepsy model corrected using targeted mesenchymal stem cell transplantation

21 January 2018

1 reference

Immunomodulatory treatments in epilepsy

21 January 2018

1 reference

Bone marrow mesenchymal stromal cells to treat complications following allogeneic stem cell transplantation

21 January 2018

1 reference

Intraarterial transplantation of human umbilical cord blood mononuclear cells is more efficacious and safer compared with umbilical cord mesenchymal stromal cells in a rodent stroke model

21 January 2018

1 reference

The cerebral embolism evoked by intra-arterial delivery of allogeneic bone marrow mesenchymal stem cells in rats is related to cell dose and infusion velocity

21 January 2018

1 reference

Intra-arterial injection of neural stem cells using a microneedle technique does not cause microembolic strokes

21 January 2018

1 reference

The Treatment Gap in Epilepsy: The Current Situation and Ways Forward

21 January 2018

1 reference

Dietary treatment of intractable epilepsy

21 January 2018

1 reference

12 December 2020

Mesenchymal stem cells protect CNS neurons against glutamate excitotoxicity by inhibiting glutamate receptor expression and function

1 reference

12 December 2020

Metabolic factors during prolonged seizures and their relation to nerve cell death.

1 reference

12 December 2020

Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study

1 reference

12 December 2020

[Partial epilepsy and corpus callosum involvement]

1 reference

12 December 2020

Low morbidity and mortality of status epilepticus in children

1 reference

12 December 2020

Improvement of the pilocarpine epilepsy model in rat using bone marrow stromal cell therapy

1 reference

12 December 2020

Mesenchymal Stem Cells

1 reference

12 December 2020

Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus

1 reference

12 December 2020

Medial ganglionic eminence-derived neural stem cell grafts ease spontaneous seizures and restore GDNF expression in a rat model of chronic temporal lobe epilepsy

1 reference

12 December 2020

Identifiers

DOI

10.1002/STEM.2029

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25851047 AND SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25851047 AND SRC:MED&resulttype=core&format=json

4 March 2020

PubMed publication ID

25851047

1 reference